Phase I study to Evaluate the Safety, tolerability and Immunogenicity of BBILs Inactivated Japanese Encephalitis Virus Vaccine in healthy volunteers. - JENVAC Phase I
Latest Information Update: 14 Dec 2018
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Adverse reactions
- Sponsors Bharat Biotech
- 26 Aug 2016 New trial record